Fluoroazomycin arabinoside F-18
- Generic Name
- Fluoroazomycin arabinoside F-18
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C8H10FN3O5
- CAS Number
- 864084-85-5
- Unique Ingredient Identifier
- UG7I3Y42PV
- Background
Fluoroazomycin arabinoside F-18 is under investigation in clinical trial NCT03257150 (A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer).
- Associated Conditions
- -
- Associated Therapies
- -
FAZA PET/MRI Pancreas
Not Applicable
Active, not recruiting
- Conditions
- First Posted Date
- 2020-05-20
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 20
- Registration Number
- NCT04395469
- Locations
- 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
FAZA PET/MRI Sarcoma
- First Posted Date
- 2018-02-01
- Last Posted Date
- 2023-10-27
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 40
- Registration Number
- NCT03418818
- Locations
- 🇨🇦
University Health Network, Toronto, Ontario, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath